The revelation about COVID 19 Vaccine and Cancer therapy
There has already been
discussion of a vaccine when this coronavirus pandemic halted the planet back
in March. Vaccines against COVID-19 have been found to be our best chance of
viral suppression and normalising again. And academics and scientists from
around the world have been struggling with this for the past 8 months. More
than 300 separate vaccines are now being made, many of them in the final test
phases.
Now that initial results
from multiple trials are announced, the expectation is increasing. We would
like to ensure that all have accessibility to details about the vaccine
COVID-19 and what it might imply for individuals living with cancer treatment in Dubai, as the latest evidence and data appeared, so we are improving
this blog posting.
The vaccines were first administered to high-risk
populations. Is that a community of
cancer patients and survivors?
People with cancers
included. Nobody with cancer is more likely to suffer from a COVID-19 infection
than the general public irrespective of the level of therapy they are under.
The same happens to patients in nursing homes and in other environments where
the effects of having COVID-19 are especially bad. They have a wide number of
prior illnesses – elevated blood pressure, heart disease, diabetes. It is less
evident to cancer patients. The main individuals who take vaccination are
health professionals who are more likely to be subjected to the virus in
emergency departments, ICUs and similar environments. In high-risk
environments, vaccination is starting and will grow as availability increases.
We can also refer to the best clinics for plastic surgery in Dubai.
Would cancer be negatively affected by the vaccine?
Cancer therapy is difficult to be impacted,
but there is no awareness at this point about the vaccine's associations with
cancer or patients with cancer. Your cancer drugs will definitely adversely
impact your vaccine because your immune system functions and most cancer
therapies inhibit your immune reaction. It could happen with patients who are
under active care that the vaccine won't perform well enough. And if cancer
therapy reduces the vaccine potency by up to 50%, it's always worth it, since
that's fine, so you're at most 50% safe.
Should you be worried about vaccine safety?
We have a clear sense of
efficacy and the first results from these clinical trials show that the
vaccinations are effective in tens of thousands of people who undergo
vaccination with the Pfizer and the Moderna vaccines. The regulatory
authorities and the committees who will allow this vaccine for use will
evaluate safety very carefully, so we trust that it is an appropriate safety
profile that an authorised vaccine can have. If hundreds of thousands of
participants in these clinical trials were vaccinated, we're much more aware of
what the protection signature for the great majority of citizens appears like.
Advancement of COVID-19 study vs cancer.
In an excellent ten-month
stretch, the advancement of many COVID-19 vaccinations raises concerns as to
why such groundbreaking measures have not resulted in the treatment of cancer.
Cancers are extremely
varied and complicated in morphology, genetics and behaviour, with over 200
distinct varieties. Not just that, but the particular cancer is special to
itself, so one treatment can never be extended to all. It is very doubtful.
Cancer will grow, adjust, expand and gradually grow in the immune system, which
is one of our researchers' greatest challenges. COIVD-19 appears not to change
its composition like cancer easily at present. And COVID-19 has helped
researchers to identify clear virus targets that render it simpler than cancer
to treat.
